TRAF4 overexpression is a common characteristic of human carcinomas
- PMID: 16799635
- DOI: 10.1038/sj.onc.1209762
TRAF4 overexpression is a common characteristic of human carcinomas
Abstract
Tumor necrosis factor receptor (TNFR) associated factor 4 (TRAF4) was initially identified as a gene amplified and overexpressed in breast carcinomas. Our aim was to evaluate whether TRAF4 protein overexpression exists in other cancer types. Immunohistochemistry analysis of tumor samples from 623 patients with 20 different tumor types showed that TRAF4 was overexpressed in 268 tumors (43%), including 82 of 137 lung adenocarcinomas (60%). Interestingly, 32 primary tumors and their matching metastases exhibited mostly similar TRAF4 expression pattern. TRAF4 protein overexpression was limited to cancer cells and the subcellular localization was consistently cytoplasmic in a large majority of cases. To investigate changes in TRAF4 gene copy number, 125 cases from six different types of carcinomas were also analysed by fluorescence in situ hybridization. Out of the 28 cases (22%) showing an increased TRAF4 gene copy number, 23 (82%) were overexpressing the protein. Thus, TRAF4 gene amplification is one of the mechanisms responsible for TRAF4 protein overexpression in human cancers. Considering that TRAF4 is located at 17q11.2 in a region of amplification devoid of known oncogenes and is commonly overexpressed in cancer, our data support an oncogenic role for TRAF4.
Similar articles
-
Tumor necrosis factor receptor-associated factor 4 is a dynamic tight junction-related shuttle protein involved in epithelium homeostasis.PLoS One. 2008;3(10):e3518. doi: 10.1371/journal.pone.0003518. Epub 2008 Oct 27. PLoS One. 2008. PMID: 18953416 Free PMC article.
-
[Expression and significance of TRAF4 protein in breast carcinoma].Ai Zheng. 2007 Oct;26(10):1095-8. Ai Zheng. 2007. PMID: 17927880 Chinese.
-
Amplified in breast cancer 1 in human epidermal growth factor receptor - positive tumors of tamoxifen-treated breast cancer patients.Clin Cancer Res. 2007 Mar 1;13(5):1405-11. doi: 10.1158/1078-0432.CCR-06-1933. Clin Cancer Res. 2007. PMID: 17332282
-
TRAF4, the unique family member.Adv Exp Med Biol. 2007;597:60-71. doi: 10.1007/978-0-387-70630-6_5. Adv Exp Med Biol. 2007. PMID: 17633017 Review.
-
Gene amplification in cancer.Trends Genet. 2006 Aug;22(8):447-55. doi: 10.1016/j.tig.2006.06.007. Epub 2006 Jun 19. Trends Genet. 2006. PMID: 16787682 Review.
Cited by
-
TRAF4 is a critical molecule for Akt activation in lung cancer.Cancer Res. 2013 Dec 1;73(23):6938-50. doi: 10.1158/0008-5472.CAN-13-0913. Epub 2013 Oct 23. Cancer Res. 2013. PMID: 24154876 Free PMC article.
-
TRAF4 binds to the juxtamembrane region of EGFR directly and promotes kinase activation.Proc Natl Acad Sci U S A. 2018 Nov 6;115(45):11531-11536. doi: 10.1073/pnas.1809599115. Epub 2018 Oct 23. Proc Natl Acad Sci U S A. 2018. PMID: 30352854 Free PMC article.
-
Drosophila p53 tumor suppressor directly activates conserved asymmetric stem cell division regulators.iScience. 2024 Oct 9;27(11):111118. doi: 10.1016/j.isci.2024.111118. eCollection 2024 Nov 15. iScience. 2024. PMID: 39524346 Free PMC article.
-
Genetic Alterations of TRAF Proteins in Human Cancers.Front Immunol. 2018 Sep 20;9:2111. doi: 10.3389/fimmu.2018.02111. eCollection 2018. Front Immunol. 2018. PMID: 30294322 Free PMC article. Review.
-
Early Biomarkers Associated with P53 Signaling for Acute Radiation Injury.Life (Basel). 2022 Jan 11;12(1):99. doi: 10.3390/life12010099. Life (Basel). 2022. PMID: 35054492 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources